5-[7-(Methylsulfonyl)-2-(4-morpholinyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-pyrimidinamine(CAS: 1007207-67-1)

This compound is a crystalline solid with a molecular weight of approximately 534.67 g/mol. It has good solubility in common organic solvents like DMSO and poor solubility in water. The compound displays high reactivity in the presence of nucleophiles, particularly in a basic environment. It also shows good stability in acidic conditions but requires protection from moisture and light.

This compound is typically synthesized via a multistep process involving the coupling of a 4-morpholinyl derivative with a 7-(methylsulfonyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-ylamine, followed by pyrimidine condensation. The reaction is catalyzed by a phase-transfer catalyst such as tetrabutylammonium fluoride, and it proceeds with good yield and selectivity under anhydrous and inert conditions.

This compound is primarily used in the pharmaceutical industry, particularly in the development of antiviral and antifungal drugs. It also has potential applications in the polymer industry for the modification of materials and in sensor technology for detection of specific analytes.

Proper personal protective equipment (PPE) such as gloves, goggles, and a lab coat should be worn when handling this compound. It should be stored in a cool, dry place away from direct sunlight and moisture. In case of spill, it should be carefully absorbed with paper towels and disposed of according to local regulations. Always refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.